
|Articles|June 15, 2003
Allergan, ACADIA to work on new drug chemistries
San Diego-ACADIA Pharmaceuticals will collaborate with Allergan Inc. to develop eye-care applications related to chemistries that ACADIA has identified for a wide range of G-protein coupled receptor and nuclear receptor targets.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Eyes on May 2026: A month of durable therapies, a regulatory reversal, and rethought echanisms
2
Reasoning prompts sharpen multimodal AI on bilingual ophthalmology exam questions
3
TECNIS PureSee IOL launches in US following FDA approval for cataract surgery
4
Beyond the Walls: Leading with love, loyalty, and a team first philosophy with Vance Thompson, MD
5





















